PT  - JOURNAL ARTICLE
AU  - Kimberley Durno
AU  - Melanie E Powell
TI  - The role of radiotherapy in ovarian cancer
AID  - 10.1136/ijgc-2021-002462
DP  - 2022 Mar 01
TA  - International Journal of Gynecologic Cancer
PG  - 366--371
VI  - 32
IP  - 3
4099  - http://ijgc.bmj.com/content/32/3/366.short
4100  - http://ijgc.bmj.com/content/32/3/366.full
SO  - Int J Gynecol Cancer2022 Mar 01; 32
AB  - Epithelial ovarian cancer accounts for around 1.9% of all malignancies and often presents late at an advanced stage. Prognosis is therefore poor. Currently the mainstay of treatment is radical cytoreductive surgery and chemotherapy but, in the past, the standard of care also included adjuvant whole abdominal radiotherapy. This is no longer standard practice, largely due to high toxicity rates and the effectiveness of platinum-based chemotherapy. Presently, a role is emerging for modern radiotherapy techniques in both the salvage and palliative settings. This review aims to examine the historical use of radiotherapy in ovarian cancer before looking forward to its potential future role.